SCHEMBL111353

SCHEMBL111353

CC(C)(O)CCCC1=CCCCC1

nearest known ligand 0.47

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
ALOX15 P16050 2/20 0.42
PKM P14618 1/20 0.42
SMN1; SMN2 Q16637 6/20 0.40
LMNA P02545 2/20 0.39
TAAR1 Q96RJ0 1/20 0.38
RAB9A P51151 6/20 0.38
NPC1 O15118 4/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
HTT P42858 1/20 0.38
HPGD P15428 1/20 0.37
USP2 O75604 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formaldehyde SCHEMBL28262224 0.95 ALDH1A1 (0.47) ALDH1A1ALOX15PKMSMN1; SMN2LMNA
SCHEMBL6565906 0.95 ALDH1A1 (0.41) ALDH1A1ALOX15PKMSMN1; SMN2LMNA
Pyrrole SCHEMBL28288914 0.92 ALDH1A1 (0.42) ALDH1A1ALOX15PKMSMN1; SMN2LMNA
SCHEMBL4992463 0.81 ALDH1A1 (0.39) ALDH1A1ALOX15PKMSMN1; SMN2LMNA
SCHEMBL10948510 0.80 ALDH1A1 (0.49) ALDH1A1ALOX15SMN1; SMN2LMNATAAR1
SCHEMBL28290439 0.80 ALDH1A1 (0.36) ALDH1A1SMN1; SMN2LMNARAB9ANPC1
SCHEMBL3893410 0.78 ALDH1A1 (0.40) ALDH1A1ALOX15PKMSMN1; SMN2RAB9A
SCHEMBL8671709 0.78 ALDH1A1 (0.50) ALDH1A1ALOX15PKMSMN1; SMN2TAAR1
SCHEMBL9348221 0.78 ALDH1A1 (0.39) ALDH1A1ALOX15PKMSMN1; SMN2LMNA
SCHEMBL9343927 0.78 NPC1 (0.49) ALDH1A1ALOX15PKMSMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 744 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025051371-A1 A FRAGRANCE PASTILLE SYMRISE AG (DE) 2025-03-13 WO claimed
US-12234253-B2 Silicone compounds with a substituted amine group and a benefit agent moiety THE PROCTER & GAMBLE COMPANY (US) 2025-02-25 US claimed
US-20250051370-A1 SILICONE COMPOUNDS PROCTER & GAMBLE (US) 2025-02-13 US claimed
CN-117982698-A Vehicle-mounted fragrance and preparation method thereof 广州汽车集团股份有限公司 2024-05-07 CN claimed
CN-117396586-A 1, 4-butanediol mono-or diesters as fragrance chemicals 巴斯夫欧洲公司 2024-01-12 CN claimed
CN-116568786-A Synergistic perfuming composition 弗门尼舍有限公司 2023-08-08 CN claimed
US-20220064191-A1 SILICONE COMPOUNDS PROCTER & GAMBLE (US) 2022-03-03 US claimed
EP-3649184-A1 SILICONE COMPOUNDS The Procter and Gamble Company (US) 2020-05-13 EP claimed
EP-3649183-A1 SILICONE COMPOUNDS The Procter and Gamble Company (US) 2020-05-13 EP claimed
EP-3423028-B1 METHOD FOR THE PRODUCTION OF ENCAPSULATED FRAGRANCE WITH IMPROVED STABILITY AGAINST DETERGENTS SYMRISE AG (DE) 2020-04-08 EP claimed
WO-2011143242-A2 FRAGRANT FORMULATIONS, METHODS OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME SEGETIS, INC. (US) 2011-11-17 WO claimed
US-20110274643-A1 FRAGRANT FORMULATIONS, METHODS OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME SEGETIS, INC. (US) 2011-11-10 US claimed
US-7638479-B2 3-methylbenzyl-isobutyrate SYMRISE GMBH & CO. KG (DE) 2009-12-29 US claimed
US-20090131299-A1 3-Methylbenzyl-Isobutyrate SYMRISE GMBH & CO. KG (DE) 2009-05-21 US claimed
EP-1123376-B1 LAUNDRY AND CLEANING COMPOSITIONS PROCTER & GAMBLE (US) 2006-09-13 EP claimed
EP-1218023-B1 METHOD FOR CALMING HUMAN BEINGS USING PERSONAL CARE COMPOSITIONS JOHNSON & JOHNSON CONSUMER (US) 2005-12-28 EP claimed
EP-1093357-B1 METHOD OF REDUCING OR PREVENTING MALODOUR QUEST INT (NL) 2004-01-07 EP claimed
US-6540988-B1 Topically applying a perfume component which is capable of inhibiting bacterial 4-ene reductase and/or 5-alpha-reductase to inhibit production of odoriferous steroids by microorganisms QUEST INTERNATIONAL B.V. (NL) 2003-04-01 US claimed
EP-1093357-A1 METHOD OF REDUCING OR PREVENTING MALODOUR QUEST INTERNATIONAL B.V. (NL) 2001-04-25 EP claimed
WO-2000001358-A1 METHOD OF REDUCING OR PREVENTING MALODOUR QUEST INTERNATIONAL B.V. (NL) 2000-01-13 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110274643-A1 FRAGRANT FORMULATIONS, METHODS OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME FASN, ELOVL6, ALOX5 ALDH1A1 505/4885ALOX15 27/4885PKM 219/4885
US-20250051370-A1 SILICONE COMPOUNDS SMCHD1, SRI, SMS ALDH1A1 3917/4885ALOX15 2271/4885PKM 1794/4885
US-12234253-B2 Silicone compounds with a substituted amine group and a benefit agent moiety SMS, SRM, AAAS ALDH1A1 3361/4885ALOX15 2826/4885PKM 2084/4885
US-20090131299-A1 3-Methylbenzyl-Isobutyrate ABAT, GABRB3, GABBR1 ALDH1A1 141/4885ALOX15 3615/4885PKM 1612/4885
US-20220064191-A1 SILICONE COMPOUNDS SMCHD1, SRI, SMS ALDH1A1 3917/4885ALOX15 2271/4885PKM 1794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.